Stock MRNS MARINUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Marinus Pharmaceuticals, Inc.

Equities

MRNS

US56854Q2003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.405 USD -1.06% Intraday chart for Marinus Pharmaceuticals, Inc. +1.81% -87.07%
Apr. 17 Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating MT
Apr. 16 Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. MRNS Stock
  4. Revisions Marinus Pharmaceuticals, Inc.